Skip to content

MiMedx Group MDXG Debt-to-assets

Debt-to-assets at other companies

IAR
Integra LifeSciencesIART
0.6×+0.1×
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
0.1×0.0×
Artivion logo
ArtivionAORT
0.3×-0.2×
Solventum logo
SolventumSOLV
0.4×-0.1×
Vericel logo
VericelVCEL
0.2×0.0×
Enovis logo
EnovisENOV
0.4×+0.1×

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Calculated from MiMedx Group’s reported figures.

Based on the most recent quarter.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's debt-to-assets?
MiMedx Group (MDXG) reported debt-to-assets of 0.1× in Q1 2026.
How has MiMedx Group's debt-to-assets changed year-over-year?
MiMedx Group's debt-to-assets decreased by 17.4% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for MiMedx Group's debt-to-assets?
Over 5 years (2020 to 2025), MiMedx Group's debt-to-assets has grown at a -23.8% compound annual growth rate (CAGR), from 0.3× to 0.1×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.